プロフィール

院長:矢田 典久

 

【略歴】
■1999年 滋賀医科大学医学部 卒業
■1999年 神戸市立中央市民病院(現 神戸市立医療センター中央市民病院) 内科研修医
■2001年 市立岸和田市民病院 消化器内科嘱託医
■2004年 京都大学大学院 内科系専攻 消化器内科学
■2008年 近畿大学医学部 消化器内科 助教
■2010年 近畿大学医学部 消化器内科 講師
■2017年 やだ消化器内視鏡クリニック 院長

 

【所属学会・専門医資格】
■日本内科学会 総合内科専門医・認定内科医
■日本消化器病学会 専門医
■日本消化器内視鏡学会 専門医
■日本肝臓病学会 専門医
■日本超音波医学会 指導医・専門医
・用語・診断基準作成委員会;肝臓のElastic imagingに関する用語・診断基準作成小委員会オブザーバー
・「日本超音波医学会 超音波エラストグラフィ診療ガイドライン:肝臓」作成
■日本ヘリコバクター学会 H. pylori(ピロリ菌)感染症認定医

 

【科学研究費】
■平成23-25年度厚生労働省科学研究費補助金(難病・がん等の医療の実用化研究事業≪肝炎関係研究分野≫)
「慢性ウイルス性肝疾患の非侵襲的線維化評価法の開発と臨床的有用性の確立」(工藤班)分担研究者
■平成26年度厚生労働省科学研究委託費(肝炎等緊急克服対策研究事業)
「慢性ウイルス性肝炎の病態把握(重症度・治療介入時期・治療効果判定・予後予測)のための非侵襲的病態診断アルゴリズムの確立」(工藤班)分担研究者
■平成27-28年度日本医療研究開発機構AMED委託研究開発費(肝炎等緊急克服対策研究事業)
「慢性ウイルス性肝炎の病態把握(重症度・治療介入時期・治療効果判定・予後予測)のための非侵襲的病態診断アルゴリズムの確立」(工藤班)分担研究者

 

【受賞歴】
■2015年2月
肝血流動態・機能イメージ研究会 坂井悠二賞「C型慢性肝炎のインターフェロン治療効果から考えるStrain elastographyおよびShear wave elastography同時観察による肝の病態把握の可能性」

 

【査読委員】
■Journal of Gastroenterology
■Journal of Gastroenterology and Hepatology
■Journal of Medical Ultrasonics
■Internal Medicine

 

【論文】
Sofue K, Tsurusaki M, Mileto A, Hyodo T, Sasaki K, Nishii T, Chikugo T, Yada N, Kudo M, Sugimura K, Murakami T: Dual-Energy CT for Noninvasive Staging of Liver Fibrosis: Accuracy of Iodine Density Measurements from Contrast-Enhanced Data. Hepatol Res. 2018 Jun 16. doi: 10.1111/hepr.13205. [Epub ahead of print]

Tamaki N, Koizumi Y, Hirooka M, Yada N, Takada H, Nakashima O, Kudo M, Hiasa Y, Izumi N: Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method. Hepatol Res. 2018 Apr 21. doi: 10.1111/hepr.13179. [Epub ahead of print]

Arizumi T, Minami T, Chishina H, Kono M, Takita M, Yada N, Hagiwara S, Minami Y, Ida H, Ueshima K, Kamata K, Minaga K, Komeda Y, Takenaka M, Sakurai T, Watanabe T, Nishida N, Kudo M: Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2. Dig Dis. 2017;35:589-597.

Arizumi T, Minami T, Chishina H, Kono M, Takita M, Yada N, Hagiwara S, Minami Y, Ida H, Ueshima K, Kamata K, Minaga K, Komeda Y, Takenaka M, Sakurai T, Watanabe T, Nishida N, Kudo M: Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2. Dig Dis. 2017;35:583-588.

Ida H, Hagiwara S, Kono M, Minami T, Chishina H, Arizumi T, Takita M, Yada N, Minami Y, Ueshima K, Nishida N, Kudo M: Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection. Dig Dis. 2017;35:565-573.

Kono M, Nishida N, Hagiwara S, Minami T, Chishina H, Arizumi T, Minaga K, Kamata K, Komeda Y, Sakurai T, Takenaka M, Takita M, Yada N, Ida H, Minami Y, Ueshima K, Watanabe T, Kudo M: Unique Characteristics Associated with Sustained Liver Damage in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals. Dig Dis. 2017;35:556-564.

Yada N, Tamaki N, Koizumi Y, Hirooka M, Nakashima O, Hiasa Y, Izumi N, Kudo M: Diagnosis of Fibrosis and Activity by a Combined Use of Strain and Shear Wave Imaging in Patients with Liver Disease. Dig Dis 2017;35:515-520.

Sakurai T, Yada N, Hagiwara S, Arizumi T, Minaga K, Kamata K, Takenaka M, Minami Y, Watanabe T, Nishida N, Kudo M.: Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma. Cancer Sci. 2017;108:1996-2003.

Arizumi T, Ueshima K, Iwanishi M, Minami T, Chishina H, Kono M, Takita M, Yada N, Hagiwara S, Minami Y, Ida H, Komeda Y, Takenaka M, Sakurai T, Watanabe T, Nishida N, Kudo M.: The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization. Liver Cancer. 2017;6:227-235.

Yada N, Sakurai T, Minami T, Arizumi T, Takita M, Hagiwara S, Ida H, Ueshima K, Nishida N, Kudo M: Influence of liver inflammation on liver stiffness measurement in patients with autoimmune hepatitis evaluation by combinational elastography. Oncology 2017;92 Suppl 1:10-15.

Toguchi M, Tsurusaki M, Yada N, Sofue K, Hyodo T, Onoda M, Numoto I, Matsuki M, Imaoka I, Kudo M, Murakami T: Magnetic resonance elastography in the assessment of hepatic fibrosis: A study comparing transient elastography and histological data in the same patients. Abdom Radiol (NY) 2017;42:1659-1666.

Kono M, Minami Y, Iwanishi M, Minami T, Chishina H, Arizumi T, Komeda Y, Sakurai T, Takita M, Yada N, Ida H, Hagiwara S, Ueshima K, Nishida N, Kudo M: Contrast-enhanced tissue harmonic imaging versus phase inversion harmonic sonographic imaging for the delineation of hepatocellular carcinomas. Oncology 2017;92 Suppl 1:29-34.

Hyodo T, Yada N, Hori M, Maenishi O, Lamb P, Sasaki K, Onoda M, Kudo M, Mochizuki T, Murakami T: Multimaterial decomposition algorithm for the quantification of liver fat content by using fast-kilovolt-peak switching dual-energy ct: Clinical evaluation. Radiology 2017;283:108-118.

Yada N, Sakurai T, Minami T, Arizumi T, Takita M, Hagiwara S, Ida H, Ueshima K, Nishida N, Kudo M: Prospective risk analysis of hepatocellular carcinoma in patients with chronic hepatitis c by ultrasound strain elastography. Dig Dis 2016;34:650-653.

Takita M, Iwanishi M, Minami T, Kono M, Chishina H, Arizumi T, Yada N, Hagiwara S, Minami Y, Ida H, Ueshima K, Naoshi N, Kudo M: Monoethanolamine oleate sclerotherapy for polycystic liver disease. Dig Dis 2016;34:654-658.

Nishida N, Yada N, Hagiwara S, Sakurai T, Kitano M, Kudo M: Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2016;31:1646-1653.

Nishida N, Kono M, Minami T, Chishina H, Arizumi T, Takita M, Yada N, Ida H, Hagiwara S, Minami Y, Ueshima K, Sakurai T, Kudo M: Safety, tolerability, and efficacy of sofosbuvir plus ribavirin in elderly patients infected with hepatitis c virus genotype 2. Dig Dis 2016;34:632-639.

Minami Y, Minami T, Chishina H, Kono M, Arizumi T, Takita M, Yada N, Hagiwara S, Ida H, Ueshima K, Nishida N, Kudo M: Us-us fusion imaging in radiofrequency ablation for liver metastases. Dig Dis 2016;34:687-691.

Arizumi T, Ueshima K, Iwanishi M, Minami T, Chishina H, Kono M, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Ida H, Sakurai T, Kitano M, Nishida N, Kudo M: Validation of kinki criteria, a modified substaging system, in patients with intermediate stage hepatocellular carcinoma. Dig Dis 2016;34:671-678.

Yada N, Sakurai T, Minami T, Arizumi T, Takita M, Hagiwara S, Ueshima K, Ida H, Nishida N, Kudo M: A newly developed shear wave elastography modality: With a unique reliability index. Oncology 2015;89 Suppl 2:53-59.

Ueshima K, Kudo M, Tanaka M, Kumada T, Chung H, Hagiwara S, Inoue T, Yada N, Kitai S: Phase i/ii study of sorafenib in combination with hepatic arterial infusion chemotherapy using low-dose cisplatin and 5-fluorouracil. Liver Cancer 2015;4:263-273.

Sakurai T, Yada N, Watanabe T, Arizumi T, Hagiwara S, Ueshima K, Nishida N, Fujita J, Kudo M: Cold-inducible rna-binding protein promotes the development of liver cancer. Cancer Sci 2015;106:352-358.

Okada M, Murakami T, Yada N, Numata K, Onoda M, Hyodo T, Inoue T, Ishii K, Kudo M: Comparison between t1 relaxation time of gd-eob-dtpa-enhanced mri and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver. J Magn Reson Imaging 2015;41:329-338.

Nishida N, Iwanishi M, Minami T, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Ida H, Hagiwara S, Minami Y, Ueshima K, Sakurai T, Kitano M, Kudo M: Early viral response predicts the efficacy of antiviral triple therapy with simeprevir, peg-interferon and ribavirin in patients infected with hepatitis c virus genotype 1. Dig Dis 2015;33:708-714.

Nishida N, Iwanishi M, Minami T, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Ida H, Hagiwara S, Minami Y, Ueshima K, Sakurai T, Kitano M, Kudo M: Hepatic DNA methylation is affected by hepatocellular carcinoma risk in patients with and without hepatitis virus. Dig Dis 2015;33:745-750.

Minami Y, Minami T, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Tsurusaki M, Yagyu Y, Ueshima K, Nishida N, Murakami T, Kudo M: Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma: A single-center experience. Oncology 2015;89 Suppl 2:27-32.

Arizumi T, Ueshima K, Minami T, Kono M, Chishina H, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Sakurai T, Nishida N, Kudo M: Effectiveness of sorafenib in patients with transcatheter arterial chemoembolization (tace) refractory and intermediate-stage hepatocellular carcinoma. Liver Cancer 2015;4:253-262.

Arizumi T, Ueshima K, Iwanishi M, Minami T, Chishina H, Kono M, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Ida H, Minami Y, Sakurai T, Nishida N, Kitano M, Kudo M: Evaluation of art scores for repeated transarterial chemoembolization in japanese patients with hepatocellular carcinoma. Oncology 2015;89 Suppl 2:4-10.

Arizumi T, Ueshima K, Iwanishi M, Minami T, Chishina H, Kono M, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Ida H, Minami Y, Sakurai T, Kitano M, Nishida N, Kudo M: Validation of a modified substaging system (kinki criteria) for patients with intermediate-stage hepatocellular carcinoma. Oncology 2015;89 Suppl 2:47-52.

Arizumi T, Ueshima K, Iwanishi M, Chishina H, Kono M, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Ida H, Minami Y, Sakurai T, Nishida N, Kitano M, Kudo M: Real-life clinical practice with sorafenib in advanced hepatocellular carcinoma: A single-center experience second analysis. Dig Dis 2015;33:728-734.

Yada N, Sakurai T, Minami T, Arizumi T, Takita M, Inoue T, Hagiwara S, Ueshima K, Nishida N, Kudo M: Ultrasound elastography correlates treatment response by antiviral therapy in patients with chronic hepatitis c. Oncology 2014;87 Suppl 1:118-123.

Yada N, Kudo M, Kawada N, Sato S, Osaki Y, Ishikawa A, Miyoshi H, Sakamoto M, Kage M, Nakashima O, Tonomura A: Noninvasive diagnosis of liver fibrosis: Utility of data mining of both ultrasound elastography and serological findings to construct a decision tree. Oncology 2014;87 Suppl 1:63-72.

Takita M, Hagiwara S, Kudo M, Kouno M, Chishina H, Arizumi T, Kitai S, Yada N, Inoue T, Minami Y, Ueshima K: Efficacy and safety of telaprevir-based antiviral treatment for elderly patients with hepatitis c virus. Oncology 2014;87 Suppl 1:110-117.

Okada M, Wakayama T, Yada N, Hyodo T, Numata K, Kagawa Y, Nishiyama D, Miyakoshi K, Murakami T: Optimal flip angle of gd-eob-dtpa-enhanced mri in patients with hepatocellular carcinoma and liver metastasis. Abdom Imaging 2014;39:694-701.

Nishida N, Nishimura T, Nakai T, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Inoue T, Minami Y, Ueshima K, Sakurai T, Kudo M: Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinoma. Dig Dis 2014;32:658-663.

Nishida N, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Inoue T, Minami Y, Ueshima K, Sakurai T, Kudo M: Identification of epigenetically inactivated genes in human hepatocellular carcinoma by integrative analyses of methylation profiling and pharmacological unmasking. Dig Dis 2014;32:740-746.

Minami T, Minami Y, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Inoue T, Hagiwara S, Ueshima K, Nishida N, Kudo M: Combination guidance of contrast-enhanced us and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced us/fusion imaging. Oncology 2014;87 Suppl 1:55-62.

Kono M, Inoue T, Kudo M, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Minami Y, Ueshima K, Nishida N, Murakami T: Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: Results and risk factors for local recurrence. Dig Dis 2014;32:670-677.

Arizumi T, Ueshima K, Takeda H, Osaki Y, Takita M, Inoue T, Kitai S, Yada N, Hagiwara S, Minami Y, Sakurai T, Nishida N, Kudo M: Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma. J Gastroenterol 2014;49:1578-1587.

Arizumi T, Ueshima K, Chishina H, Kono M, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Sakurai T, Nishida N, Kudo M: Duration of stable disease is associated with overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib. Dig Dis 2014;32:705-710.

Arizumi T, Ueshima K, Chishina H, Kono M, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Sakurai T, Nishida N, Kudo M: Decreased blood flow after sorafenib administration is an imaging biomarker to predict overall survival in patients with advanced hepatocellular carcinoma. Dig Dis 2014;32:733-739.

Arizumi T, Ueshima K, Chishina H, Kono M, Takita M, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Sakurai T, Nishida N, Kudo M: Validation of the criteria of transcatheter arterial chemoembolization failure or refractoriness in patients with advanced hepatocellular carcinoma proposed by the lcsgj. Oncology 2014;87 Suppl 1:32-36.

Yada N, Kudo M, Morikawa H, Fujimoto K, Kato M, Kawada N: Assessment of liver fibrosis with real-time tissue elastography in chronic viral hepatitis. Oncology 2013;84 Suppl 1:13-20.

Yada N, Kudo M, Chung H, Watanabe T: Autoimmune hepatitis and immunoglobulin g4-associated autoimmune hepatitis. Dig Dis 2013;31:415-420.

Nishida N, Kudo M, Nishimura T, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Inoue T, Minami Y, Ueshima K, Sakurai T, Yokomichi N, Nagasaka T, Goel A: Unique association between global DNA hypomethylation and chromosomal alterations in human hepatocellular carcinoma. PLoS One 2013;8:e72312.

Nishida N, Arizumi T, Takita M, Nagai T, Kitai S, Yada N, Hagiwara S, Inoue T, Minami Y, Ueshima K, Sakurai T, Ida H, Kudo M: Quantification of tumor DNA in serum and vascular invasion of human hepatocellular carcinoma. Oncology 2013;84 Suppl 1:82-87.

Nishida N, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Inoue T, Minami Y, Ueshima K, Sakurai T, Kudo M: Reactive oxygen species induce epigenetic instability through the formation of 8-hydroxydeoxyguanosine in human hepatocarcinogenesis. Dig Dis 2013;31:459-466.

Kudo M, Shiina T, Moriyasu F, Iijima H, Tateishi R, Yada N, Fujimoto K, Morikawa H, Hirooka M, Sumino Y, Kumada T: Jsum ultrasound elastography practice guidelines: Liver. J Med Ultrason (2001) 2013;40:325-357.

Inoue T, Kudo M, Hatanaka K, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Minami Y, Sakurai T, Ueshima K, Nishida N: Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: Comparison with dynamic ct. Oncology 2013;84 Suppl 1:51-57.

Hagiwara S, Kudo M, Osaki Y, Matsuo H, Inuzuka T, Matsumoto A, Tanaka E, Sakurai T, Ueshima K, Inoue T, Yada N, Nishida N: Impact of peginterferon alpha-2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis b. J Med Virol 2013;85:987-995.

Fujimoto K, Kato M, Kudo M, Yada N, Shiina T, Ueshima K, Yamada Y, Ishida T, Azuma M, Yamasaki M, Yamamoto K, Hayashi N, Takehara T: Novel image analysis method using ultrasound elastography for noninvasive evaluation of hepatic fibrosis in patients with chronic hepatitis c. Oncology 2013;84 Suppl 1:3-12.

Nishida N, Arizumi T, Hayaishi S, Takita M, Kitai S, Yada N, Hagiwara S, Inoue T, Minami Y, Ueshima K, Sakurai T, Ikai I, Kudo M: Gender differences in the livers of patients with hepatocellular carcinoma and chronic hepatitis c infection. Dig Dis 2012;30:547-553.

Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T: Assessment of gd-eob-dtpa-enhanced mri for hcc and dysplastic nodules and comparison of detection sensitivity versus mdct. J Gastroenterol 2012;47:1036-1047.

Hagiwara S, Sakurai T, Takita M, Ueshima K, Minami Y, Inoue T, Yada N, Kitai S, Nagai T, Hayaishi S, Arizumi T, Nishida N, Kudo M: Risk of hepatocellular carcinoma development in cases of hepatitis c treated by long-term, low-dose peg-ifnalpha-2a. Dig Dis 2012;30:561-567.

Hagiwara S, Sakurai T, Nishina S, Tanaka K, Ikeda M, Ueshima K, Minami Y, Inoue T, Yada N, Kitai S, Takita M, Nagai T, Hayaishi S, Arizumi T, Park AM, Munakata H, Nishida N, Kudo M: Characteristic pattern of reactivation of hepatitis b virus during chemotherapy for solid cancers. Dig Dis 2012;30:541-546.

Ueshima K, Kudo M, Takita M, Nagai T, Tatsumi C, Ueda T, Kitai S, Ishikawa E, Yada N, Inoue T, Hagiwara S, Minami Y, Chung H, Sakurai T: Des-gamma-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma. Dig Dis 2011;29:321-325.

Takita M, Hagiwara S, Arizumi T, Hayaishi S, Ueda T, Kitai S, Yada N, Inoue T, Minami Y, Chung H, Ueshima K, Sakurai T, Kudo M: Association of interleukin-28b and hepatitis c genotype 1 with a high viral load and response to pegylated interferon plus ribavirin therapy. Digestion 2011;84 Suppl 1:56-61.

Hayaishi S, Chung H, Kudo M, Ishikawa E, Takita M, Ueda T, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Ueshima K: Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis. Dig Dis 2011;29:326-332.

Yada N, Kudo M, Chung H, Hayaishi S, Takita M, Ueda T, Tatsumi C, Hatanaka K, Kitai S, Ishikawa E, Inoue T, Hagiwara S, Ueshima K: Peg-ifnalpha/rbv combination therapy for chronic hepatitis c patients increases serum ferritin level while it improves sustained viral response rate. Intervirology 2010;53:60-65.

Ueshima K, Kudo M, Takita M, Nagai T, Tatsumi C, Ueda T, Kitai S, Ishikawa E, Yada N, Inoue T, Hagiwara S, Minami Y, Chung H: Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma. Oncology 2010;78 Suppl 1:148-153.

Ueda T, Chung H, Kudo M, Ishikawa E, Hayaishi S, Tatsumi C, Inoue T, Yada N, Hagiwara S, Minami Y, Ueshima K: Prolonged peg-ifn and rbv is effective in patients with hcv genotype 1 and high viral load who achieved virological response later than 24 weeks. Intervirology 2010;53:55-59.

Tatsumi C, Kudo M, Ueshima K, Kitai S, Ishikawa E, Yada N, Hagiwara S, Inoue T, Minami Y, Chung H, Maekawa K, Fujimoto K, Kato M, Tonomura A, Mitake T, Shiina T: Non-invasive evaluation of hepatic fibrosis for type c chronic hepatitis. Intervirology 2010;53:76-81.

Inoue T, Minami Y, Chung H, Hayaishi S, Ueda T, Tatsumi C, Takita M, Kitai S, Hatanaka K, Ishikawa E, Yada N, Hagiwara S, Ueshima K, Kudo M: Radiofrequency ablation for hepatocellular carcinoma: Assistant techniques for difficult cases. Oncology 2010;78 Suppl 1:94-101.

Hatanaka K, Chung H, Kudo M, Haji S, Minami Y, Maekawa K, Hayaishi S, Nagai T, Takita M, Kudo K, Ueda T, Tatsumi C, Kitai S, Ishikawa E, Yada N, Inoue T, Hagiwara S, Ueshima K: Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma. Oncology 2010;78 Suppl 1:53-59.

Uenoyama Y, Seno H, Fukuda A, Sekikawa A, Nanakin A, Sawabu T, Kawada M, Kanda N, Suzuki K, Yada N, Fukui H, Chiba T: Hypoxia induced by benign intestinal epithelial cells is associated with cyclooxygenase-2 expression in stromal cells through ap-1-dependent pathway. Oncogene 2006;25:3277-3285.

Hagihara S, Kasahara K, Yada N, Mouri Y, Kimura N, Takaya H, Kajimura K: [a case of autoimmune pancreatitis with harada’s disease]. Nihon Shokakibyo Gakkai Zasshi 2003;100:1134-1139.